Have a feature idea you'd love to see implemented?
Let us know!
AORT Artivion Inc
Price (delayed)
$26.5
Market cap
$1.11B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.21
Enterprise value
$1.42B
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins
Highlights
The net income has soared by 71% YoY and by 13% from the previous quarter
Artivion's EPS has surged by 70% YoY and by 13% QoQ
AORT's quick ratio is up by 26% year-on-year but it is down by 5% since the previous quarter
Key stats
What are the main financial stats of AORT
Market
Valuations
Earnings
Shares outstanding
41.89M
Market cap
$1.11B
Enterprise value
$1.42B
Price to earnings (P/E)
N/A
Price to book (P/B)
3.75
Price to sales (P/S)
2.93
EV/EBIT
48.33
EV/EBITDA
23.5
EV/Sales
3.76
Revenue
$376.97M
EBIT
$29.32M
EBITDA
$60.32M
Free cash flow
$9.19M
Per share
Balance sheet
Liquidity
EPS
-$0.21
Free cash flow per share
$0.22
Book value per share
$7.07
Revenue per share
$9.04
TBVPS
$9.14
Total assets
$789.54M
Total liabilities
$494.48M
Debt
$362.02M
Equity
$295.06M
Working capital
$234.38M
Debt to equity
1.23
Current ratio
5.63
Quick ratio
2.65
Net debt/EBITDA
5.09
Margins
Efficiency
Dividend
EBITDA margin
16%
Gross margin
64.6%
Net margin
-2.2%
Operating margin
9%
Return on assets
-1.1%
Return on equity
-2.9%
Return on invested capital
4.7%
Return on capital employed
4%
Return on sales
7.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AORT stock price
How has the Artivion stock price performed over time
Intraday
-0.53%
1 week
0.34%
1 month
5.12%
1 year
101.67%
YTD
48.21%
QTD
-0.45%
Financial performance
How have Artivion's revenue and profit performed over time
Revenue
$376.97M
Gross profit
$243.64M
Operating income
$33.75M
Net income
-$8.36M
Gross margin
64.6%
Net margin
-2.2%
AORT's net margin has soared by 75% year-on-year and by 15% since the previous quarter
The net income has soared by 71% YoY and by 13% from the previous quarter
The company's operating income has surged by 63% QoQ
The operating margin has surged by 61% since the previous quarter
Growth
What is Artivion's growth rate over time
Valuation
What is Artivion stock price valuation
P/E
N/A
P/B
3.75
P/S
2.93
EV/EBIT
48.33
EV/EBITDA
23.5
EV/Sales
3.76
Artivion's EPS has surged by 70% YoY and by 13% QoQ
The stock's price to book (P/B) is 40% more than its 5-year quarterly average of 2.7 and 30% more than its last 4 quarters average of 2.9
Artivion's equity has increased by 4.4% YoY
The price to sales (P/S) is 28% higher than the last 4 quarters average of 2.3 and 13% higher than the 5-year quarterly average of 2.6
The company's revenue rose by 15% YoY and by 2.4% QoQ
Efficiency
How efficient is Artivion business performance
AORT's ROE has soared by 72% YoY and by 15% QoQ
AORT's return on assets has surged by 70% year-on-year and by 8% since the previous quarter
The ROIC is up by 7% QoQ
Artivion's return on sales has increased by 5% QoQ
Dividends
What is AORT's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Artivion financials performed over time
The total assets is 60% greater than the total liabilities
AORT's quick ratio is up by 26% year-on-year but it is down by 5% since the previous quarter
AORT's current ratio is up by 20% year-on-year but it is down by 7% since the previous quarter
AORT's debt is 23% greater than its equity
Artivion's equity has increased by 4.4% YoY
The debt to equity has contracted by 2.4% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.